Oruka Therapeutics, Valuation
| ORKA Stock | 20.26 1.57 8.40% |
At this time, the company appears to be undervalued. Oruka Therapeutics, holds a recent Real Value of USD25.13 per share. The prevailing price of the company is USD20.26. Our model determines the value of Oruka Therapeutics, from analyzing the company fundamentals such as Market Capitalization of 888.26 M, current valuation of 899.11 M, and Annual Yield of 0.78 % as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 899.1 M |
Undervalued
Today
Please note that Oruka Therapeutics,'s price fluctuation is not too volatile at this time. Calculation of the real value of Oruka Therapeutics, is based on 3 months time horizon. Increasing Oruka Therapeutics,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Oruka Therapeutics, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oruka Stock. However, Oruka Therapeutics,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.26 | Real 25.13 | Target 41.25 | Hype 19.99 | Naive 20.69 |
The real value of Oruka Stock, also known as its intrinsic value, is the underlying worth of Oruka Therapeutics, Company, which is reflected in its stock price. It is based on Oruka Therapeutics,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Oruka Therapeutics,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Oruka Therapeutics, helps investors to forecast how Oruka stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oruka Therapeutics, more accurately as focusing exclusively on Oruka Therapeutics,'s fundamentals will not take into account other important factors: Oruka Therapeutics, Total Value Analysis
Oruka Therapeutics, is now forecasted to have valuation of 899.11 M with market capitalization of 888.26 M, debt of , and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Oruka Therapeutics, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
899.11 M | 888.26 M |
Oruka Therapeutics, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Oruka suggests not a very effective usage of assets in November.Oruka Therapeutics, Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oruka Therapeutics,'s worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oruka Therapeutics, and how it compares across the competition.
About Oruka Therapeutics, Valuation
The stock valuation mechanism determines Oruka Therapeutics,'s current worth on a weekly basis. Our valuation model uses a comparative analysis of Oruka Therapeutics,. We calculate exposure to Oruka Therapeutics,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oruka Therapeutics,'s related companies. Oruka Therapeutics,'s stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Oruka Therapeutics,'s value is low or high relative to the company's performance and growth projections. Determining the market value of Oruka Therapeutics, can be done in different ways, such as multiplying its stock price by its outstanding shares.A single share of Oruka Therapeutics, represents a small ownership stake in the entity. As a stockholder of Oruka, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Oruka Therapeutics, Dividends Analysis For Valuation
Please note that Oruka Therapeutics, has scaled down on payment of dividends at this time.
There are various types of dividends Oruka Therapeutics, can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Oruka shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Oruka Therapeutics, directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Oruka pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Oruka Therapeutics, by the value of the dividends paid out.
Oruka Therapeutics, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Shares Short Prior Month | 783.8 K |
Complementary Tools for Oruka Stock analysis
When running Oruka Therapeutics,'s price analysis, check to measure Oruka Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oruka Therapeutics, is operating at the current time. Most of Oruka Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Oruka Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oruka Therapeutics,'s price. Additionally, you may evaluate how the addition of Oruka Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |